Mimerse secures $730K in a seed investment round to build VR-based mental health pharmacy.
Mimerse, a Stockholm, Sweden-based startup working on a VR therapy solution, annouced it has raised $730K in seed funding.
The money comes from Almi Invest and Swedish private investors, including Rikard Steiber and Tetraeder, and will be used to further the development of the company's platform, a VR pharmacy for mental health, initially focusing on phobias, pain, and stress.
Mimerse, founded in 2014 by CEO Niclas Wijkström and William Hamilton, builds evidence-based treatments using immersive technologies. Mimerse is working with leading universities and hospitals and is the first company to clinically validate an automatic VR treatment for a specific phobia. The platform to serve as a VR pharmacy is scheduled to be launched in 2019.